International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine

National Member Associations

IFAPP is comprised of the leading professional associations in the fields of Pharmaceutical Medicine and medicines development.


Worldwide Development and Professional Certification


Excellent Global Communication Since 1975


IFAPP collaborates and coordinates with key players in the fields of pharmaceutical medicine and medicines development

Certification Working Group

CCWG works collaboratively in the development and delivery of relevant and recognised education and training in PM/MDS for the benefit of IFAPP’s professional membership.

The International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine, IFAPP, since 1975

IFAPP has ever after grown steadily in size and scope. Its primary objective was to bring together physicians and scientists from the pharmaceutical industry with those working in research institutes and academic medicine and internationalise the advancement of knowledge in medicines development and pharmaceutical medicine. The increasingly important role of pharmaceutical physicians and other professionals involved in drug development process has been firmly established through numerous conferences, meetings and other events organised on the world wide level.

Currently, 22 National Member Associations (NMAs) represent the interests and goals of several thousand professionals active in Pharmaceutical Medicine

Pharmaceutical Medicine is the medical scientific discipline concerned with the discovery, development, evaluation, registration, monitoring and medical aspects of marketing of medicines for the benefit of patients and public health.

Source/Reference: The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (https://www.fpm.org.uk)

Our Latest News

FDA Basics for Industry

By Anna Jurczynska | May 2, 2018

  How do i know if my product is regulated by the FDA? It depends on what the product is…

Read More

Ten years promoting high-quality scientific research in paediatric medicines

By Anna Jurczynska | May 2, 2018

The second day of the workshop is reserved for discussions among the members of Enpr-EMA and its coordinating group. The…

Read More

Updated rules for clinical development of vaccines

By Anna Jurczynska | May 2, 2018

26/04/2018 EMA launches public consultation on revised guideline on clinical evaluation of vaccines The European Medicines Agency (EMA) has released a revised guideline on the…

Read More